| 2016 ESC/EAS guidelines for the management of dyslipidaemias AL Catapano, I Graham, G De Backer, O Wiklund, MJ Chapman, H Drexel, ... Polish Heart Journal (Kardiologia Polska) 74 (11), 1234-1318, 2016 | 8230* | 2016 |
| ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology … DP Zipes, AJ Camm, M Borggrefe, AE Buxton, B Chaitman, M Fromer, ... Europace 8 (9), 746-837, 2006 | 4681 | 2006 |
| Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European … BA Ference, HN Ginsberg, I Graham, KK Ray, CJ Packard, E Bruckert, ... European heart journal 38 (32), 2459-2472, 2017 | 3221 | 2017 |
| Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of … BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ... European heart journal 34 (45), 3478-3490, 2013 | 3005 | 2013 |
| Lipoprotein (a) as a cardiovascular risk factor: current status BG Nordestgaard, MJ Chapman, K Ray, J Borén, F Andreotti, GF Watts, ... European heart journal 31 (23), 2844-2853, 2010 | 2129 | 2010 |
| Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management MJ Chapman, HN Ginsberg, P Amarenco, F Andreotti, J Borén, ... European heart journal 32 (11), 1345-1361, 2011 | 1587 | 2011 |
| Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on … M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ... European heart journal 35 (32), 2146-2157, 2014 | 1103 | 2014 |
| Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European … J Boren, MJ Chapman, RM Krauss, CJ Packard, JF Bentzon, CJ Binder, ... European heart journal 41 (24), 2313-2330, 2020 | 1049 | 2020 |
| Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention J Millán, X Pintó, A Muñoz, M Zúñiga, J Rubiés-Prat, LF Pallardo, ... Vascular health and risk management, 757-765, 2009 | 1025 | 2009 |
| Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment A Wiegman, SS Gidding, GF Watts, MJ Chapman, HN Ginsberg, M Cuchel, ... European heart journal 36 (36), 2425-2437, 2015 | 905 | 2015 |
| Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies Triglyceride Coronary Disease Genetics Consortium, ... The Lancet 375 (9726), 1634-1639, 2010 | 754 | 2010 |
| The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management RA Hegele, HN Ginsberg, MJ Chapman, BG Nordestgaard, ... The lancet Diabetes & endocrinology 2 (8), 655-666, 2014 | 611 | 2014 |
| Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease H Gylling, J Plat, S Turley, HN Ginsberg, L Ellegård, W Jessup, PJ Jones, ... Atherosclerosis 232 (2), 346-360, 2014 | 552 | 2014 |
| EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study KK Ray, B Molemans, WM Schoonen, P Giovas, S Bray, G Kiru, J Murphy, ... European journal of preventive cardiology 28 (11), 1279-1289, 2021 | 536 | 2021 |
| ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of … European Association for Cardiovascular Prevention & Rehabilitation, ... Eur Heart J 32 (14), 1769-818, 2011 | 477 | 2011 |
| Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome J Joven, C Villabona, E Vilella, L Masana, R Albertí, M Vallés New England Journal of Medicine 323 (9), 579-584, 1990 | 398 | 1990 |
| European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to … BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ... Eur Heart J 34 (45), 3478-90a, 2013 | 252 | 2013 |
| European Atherosclerosis Society Consensus Panel on Familial Hypercholesterolaemia: Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to … M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ... Eur Heart J 35 (32), 2146-2157, 2014 | 235 | 2014 |
| Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia F Civeira, E Ros, E Jarauta, N Plana, D Zambon, J Puzo, JPM de Esteban, ... The American journal of cardiology 102 (9), 1187-1193. e1, 2008 | 219 | 2008 |
| Estándares SEA 2022 para el control global del riesgo cardiovascular JM Mostaza, X Pintó, P Armario, L Masana, JT Real, P Valdivielso, ... Clínica e investigación en arteriosclerosis 34 (3), 130-179, 2022 | 217 | 2022 |
